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DObjective: Temporary biventricular pacing to treat low output states after cardiac surgery is an active area of
investigation. Reoperative cases are not studied due to adhesions, which preclude left ventricular mobilization
to place epicardial pacing wires. In such patients, inserting a temporary left ventricular lead via the coronary
sinus cardioplegia cannula may allow for biventricular pacing. We developed a novel technique for intraoper-
ative left ventricular lead placement.
Methods: Eight domestic pigs underwent median sternotomy and pericardiotomy. Temporary pacing wires
were sewn to the right atrium and right ventricle. Complete heart block was induced by ethanol ablation of
the atrioventricular node. A 13-French retrograde cardioplegia catheter was introduced via the right atrial
free wall into the coronary sinus. A 6-French left ventricular pacing lead was inserted into the cardioplegia cath-
eter and advanced into the coronary sinus during biventricular pacing until left ventricular capture was detected
by electrocardiogram and arterial pressure monitoring. Left ventricular capture success rate and electrical per-
formance were recorded during five placement attempts.
Results: Left ventricular capture was achieved on 80% of insertion attempts. Left ventricular capture without
diaphragmatic pacing was achieved in 7 pigs. Lead tip locations were mostly in lateral and posterior basal
coronary vein branches. There were no arrhythmias, bleeding, or perforation associated with lead insertion.
Conclusions: Intraoperative biventricular pacing with a left ventricular pacing lead inserted via the coronary
sinus cardioplegia cannula is feasible, using standard instrumentation and without requiring cardiac manipula-
tion. This approachmerits further study in patients undergoing reoperative cardiac surgery. (J Thorac Cardiovasc
Surg 2011;142:73-6)In select patients with congestive heart failure (CHF), car-
diac resynchronization therapy with biventricular pacing
(BiVP) reduces morbidity.1-4 Permanent BiVP is indicated
in advanced, chronic CHF associated with left ventricular
(LV) dysfunction and intraventricular conduction delay.5
The use of BiVP acutely improves cardiac contractility
and cardiac output without increasing myocardial energy
consumption.6,7 Therefore, it represents a potential
treatment for low output heart failure after cardiac surgery,
in which low ejection fraction is a strong predictor of poor
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The Journal of Thoracic and CTemporary BiVP in the perioperative cardiac surgery set-
ting is an active area of investigation, with numerous trials
demonstrating acute improvements in cardiac output, arte-
rial pressure, and ventricular synchrony.10-18 To be able to
achieve BiVP, such protocols involve attaching temporary
pacing wires to the right atrial (RA), right ventricular
(RV), and LV epicardium. An important limitation to this
approach occurs in the setting of reoperative cardiac
surgery, where adhesions preclude adequate mobilization
of the heart to place pacing wires on the lateral or
posterior LV. Patients with reduced ejection fraction who
are undergoing reoperative surgery comprise a particularly
high-risk group19 and may especially benefit from tempo-
rary BiVP. Currently, such patients are excluded from the
study. Consequently, development of an alternative method
of achieving BiVP in these patients is needed. Here we
report the feasibility and safety of a new technique for LV
lead delivery via the coronary sinus (CS) cardioplegia
cannula during open heart surgery.
METHODS
All animal studies were performed according to the National Institutes
of Health Guide for the Care and Use of Laboratory Animals. The experi-
mental protocol was approved by the Columbia University Institutional
Animal Care and Use Committee.ardiovascular Surgery c Volume 142, Number 1 73
FIGURE 1. Inspection of the left ventricular (LV) lead location. In this
example, the tip of the LV lead is seen in an epicardial venous branch off
of the coronary sinus over the mid-lateral LV.
TABLE 1. Left ventricular lead location and electrical performance
Pig #
Capture success
rate (%)
Capture
threshold (V)
Impedance
(ohms)
Lead tip
location
1 60 1.5  0.3* 616  14 Basal lateral
2 100 2.6  1.2 1033  38 Basal lateral
Abbreviations and Acronyms
BiVP ¼ biventricular pacing
CHF ¼ congestive heart failure
CS ¼ the coronary sinus
ECG ¼ electrocardiogram
LV ¼ left ventricular
RA ¼ right atrial
RV ¼ right ventricular
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DEight Yorkshire pigs (28-33 kg) were anesthetized intramuscularly with
atropine (0.02 mg/kg), ketamine (20 mg/kg), and xylazine (0.5 mg/kg),
followed by oral endotracheal intubation and mechanical ventilation, as
previously described.20,21 Anesthesia was maintained with isoflurane
(1.75-2.5%) in oxygen. Arterial blood gas measurements were used to
guide maintenance of adequate oxygenation and ventilation. Intravenous
access was established via a posterior auricular vein, and 0.9% saline
was administered at 5 mL/kg/hr. A femoral arterial line was inserted to
measure arterial pressure. Standard limb leads were placed for surface
electrocardiogram (ECG) monitoring. Pulse oximetry was monitored
from the shaved tail. After a median sternotomy, the pericardium was
incised longitudinally and traction sutures were placed to expose and
support the heart.
Bipolar temporary epicardial pacing leads (Medtronic 6495; Medtronic,
Minneapolis,Minn) were sewn onto the RA appendage and anterior surface
of the RV. The pacing leads were attached to a biventricular pacemaker
(Medtronic InSync III) in a custom housing unit to allow lead connection
with alligator clips. Proper lead function was then confirmed. Complete
heart block was established with injection of 0.5 mL aliquots of 100% eth-
anol into the region of the bundle of His, at the base of the aorta, as previ-
ously described.22
A 13-French retrograde cardioplegia cannula was inserted via a RA free
wall incision into the proximal CS and secured with a pursestring suture.
Using the cardioplegia cannula as a guiding sheath, a 6-French bipolar
LV pacing lead (Medtronic Attain 4194) with a stylet was inserted into
the cardioplegia cannula and advanced into the CS. The LV lead was con-
nected to the biventricular pacemaker, programmed at DDD 90 and an
atrioventricular delay of 150 msec. Without lifting the heart, the lead
was slowly advanced until LV capture was detected on ECG and confirmed
by arterial pressure monitoring and visual inspection during LV pacing
alone. Pacing function, including impedance and capture threshold, was
measured with the stylet slightly withdrawn. If diaphragmatic stimulation
was present, the lead was slowly advanced and empirically torqued clock-
wise or counterclockwise, as needed, until ventricular pacing without dia-
phragmatic stimulation was achieved, and thresholds and impedances were
retested. Both bipolar and unipolar pacing configurations were tested to
achieve the optimal pacing performance. After a minimum of 1-minute
pacing, the lead was withdrawn from the cardioplegia cannula. Five inser-
tion trials were tested for each animal. After the fifth trial, the heart was
lifted and visually inspected for any evidence of bleeding or perforation,
and the location of the LV lead tip was noted (Figure 1). ECG monitoring
for arrhythmias was conducted throughout the experiment. The animals
were humanely killed at the end of the experiment.3 100 3.4  1.2 1007  35 Basal lateral
4 80 5.9  1.0 811  22 Mid anterior
5 60 1.7  0.2 1932  88 Basal posterior
6 100 1.6  0.4 1600  80 Basal posterior
7 40 0.8  0.3 652  20 Basal posterior
8 100 5.3  1.4 829  85 Mid lateral
*Mean  1 standard error of the mean.RESULTS
Capture success rates, electrical performance, and lead
locations for each animal are shown in Table 1. There
were no episodes of arrhythmia, bleeding, perforation, or
hemodynamic compromise during lead placement attempts.74 The Journal of Thoracic and Cardiovascular SurgeThe overall capture success rate for all attempts was 80%.
The LV capture was achieved on at least one attempt in all 8
animals. In one animal, diaphragmatic pacing could not be
avoided, despite lead repositioning and adjustment of pac-
ing output and polarity. In the majority of animals, the LV
lead tip was found to be in a coronary vein in the lateral
or posterior aspect of the LVwall. Themost common reason
for failure to capture the LV was due to coursing of the LV
lead into the left hemiazygous vein.DISCUSSION
In patients with postoperative low output syndrome,
temporary BiVP to improve hemodynamics and ventricu-
lar mechanics is an active area of investigation.10-18
Patients undergoing reoperative cardiac surgery comprise
a particularly high-risk group.19 Thus, new techniques
for temporary LV pacing are needed, so that the role of
temporary BiVP can be studied in this cohort. To our
knowledge, this is the first report of such a technique.
We demonstrate the feasibility and safety of a novel
method for achieving temporary BiVP during open heart
surgery. Our model replicates a common clinical techniquery c July 2011
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The cardioplegia cannula not only accesses the CS, but it
also it serves as a guiding sheath to direct the LV lead
into a coronary branch vein, thereby addressing two major
challenges to successful LV lead implantation in permanent
cardiac resynchronization therapy. 23 Without using fluoro-
scopic imaging, LV capture was achieved in 80% of lead
placement attempts, and LV capture without diaphragmatic
stimulation was achieved in 7 of the 8 animals.
In the majority of cases, the LV lead was in a lateral or
posterior position, which are considered to be generally fa-
vorable positions for BiVP.24 We found that, in the majority
of failures to capture the LV, the LV lead had coursed into
the left hemiazygous vein. This problem would not arise
in humans, as the left hemiazygous vein drains directly
into the CS in pigs but not humans.25
The model used here is only an approximation of the
conditions during cardiac surgery, as cardiopulmonary by-
pass and cardioplegia were not used. Extension of the de-
scribed technique to clinical reoperations would require
a number of modifications. First, the LV lead would need
to be introduced immediately following the last dose of ret-
rograde cardioplegia and immediately before removal of
the cardioplegia cannula. Next, final lead positioning and
threshold testing would ideally be done on partial bypass,
when electrophysiologic properties of the myocardium
have recovered toward normal. Final lead positioning
should also be done immediately before weaning from by-
pass, when the heart is maximally filled. This latter step
would avoid lateral displacement of the right atrial wall
by volume infusion from pulling the LV lead out of its
optimized position.
Perioperative cardiac resynchronization is also being
studied in pediatric patients undergoing surgery for congen-
ital heart disease.26,27 This technique may provide an
alternative approach to multi-site pacing in such patients.
Use of intraoperative transesophageal echocardiography
may improve the success rate of LV lead placement.28 In
the future, hybrid operating rooms offering fluoroscopic im-
aging will refine vein selection and lead localization. Fur-
thermore, specialized endocardial LV leads and lead
delivery systems, designed specifically for temporary
BiVP via the CS, may further improve the efficacy and
safety of this approach. The safety and feasibility of this
technique warrants further study in human subjects under-
going reoperative cardiac surgery.
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